352 results
-
List item
Orphan designation: Aztreonam lysinate for: Treatment of Gram-negative bacterial lung infection in cystic fibrosis
Date of designation: 21/06/2004, Expired, Last updated: 16/10/2019oral, intravenous and as an aerosol via nebulisation in the lungs … -
List item
Orphan designation: ciclosporin for: Prevention of graft rejection after lung transplantation
Date of designation: 29/07/2004, Positive, Last updated: 10/07/2019European Commission to PARI Aerosol Research Institute, Germany … European Commission to PARI Aerosol Research Institute, Germany … -
List item
Orphan designation: Pegylated recombinant anti-Pseudomonas aeruginosa antibody for: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Date of designation: 05/08/2013, Withdrawn, Last updated: 06/03/2015changes the solution into an aerosol so that the patient can breathe … changes the solution into an aerosol so that the patient can breathe … -
List item
National expert: Jens-Uwe Bleich, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.7 KB | PDF
- Curriculum Vitae - 25.79 KB | PDF
B.W. and Waßmus, W. (1993) Aerosol Solvent Extraction System … abbaubarer Mikropartikel mit dem Aerosol Solvent Extraction System … supercritical gases with the Aerosol Solvent Extraction System … -
List item
National expert: Serena Zamponi, Italian Medicines Agency (updated)
- Declaration of interests - 39.32 KB | PDF
- Curriculum Vitae - 25.9 KB | PDF
Employer: ACRAF S.p.a. _ Angelini • Start date: 112009 • … -
List item
National expert: Anita Simonds, European Medicines Agency (updated)
- Declaration of interests - 41.83 KB | PDF
- Curriculum Vitae - 38.3 KB | PDF
patients with COVID_19 receiving aerosol_generating procedures. Thorax 2021 doi:10.1136/thoraxjnl_2021_218035 … evidence gaps and the risks of aerosol transmission of SARS_CoV_2 … -
List item
National expert: Heidi Mestl, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.27 KB | PDF
- Curriculum Vitae - 188.99 KB | PDF
Emissions of Carbonaceous Aerosol and Other Air Pollutants … Mellouki, Fahe Chai, Shulan Wang. Aerosol and Air Quality Research … -
List item
National expert: Georgia Valsami, National Organization For Medicines (updated)
- Declaration of interests - 41.09 KB | PDF
- Curriculum Vitae - 225.07 KB | PDF
of Athens, Pharmaten S.A., Angelini S.A., aViPharma S.A. (completed … -
List item
National expert: Juan Pablo Horcajada, European Medicines Agency (updated)
- Declaration of interests - 44.11 KB | PDF
- Curriculum Vitae - 41.29 KB | PDF
INFECTIONS null Past 01-01- 2021 01-06- 2021 Angelini Cross product related … -
List item
National expert: Diego Alejandro Dri, Italian Medicines Agency (updated)
- Declaration of interests - 41.04 KB | PDF
- Curriculum Vitae - 32.42 KB | PDF
declared Other comments Angelini Acraf S.p.A. null Spouse … -
List item
Human medicine European public assessment report (EPAR): Adasuve
loxapine, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/02/2013, Revision: 14, Authorised, Last updated: 14/11/2022 -
List item
Orphan designation: Tobramycin for: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Date of designation: 17/03/2003, Expired, Last updated: 31/07/2023oral, intravenous and as an aerosol via nebulisation. Several … oral, intravenous and as an aerosol via nebulisation. Several … -
List item
National expert: Eamon O Murchu, Health Products Regulatory Authority (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 35.97 KB | PDF
transmission of SARS-CoV-2 via aerosols.13. Publications Page 2 … -
List item
National expert: Kaisa Mari Hämäläinen, Finnish Medicines Agency (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 32.19 KB | PDF
of asthma in children. J Aerosol Med 2004, 17:15_24. 2. Toropainen … -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 16, Authorised, Last updated: 08/09/2023 -
List item
Human medicine European public assessment report (EPAR): Xydalba
dalbavancin hydrochloride, Soft Tissue Infections; Skin Diseases, Bacterial
Date of authorisation: 19/02/2015, Revision: 15, Authorised, Last updated: 01/08/2023 -
List item
Human medicine European public assessment report (EPAR): Vantobra (previously Tobramycin PARI) (updated)
Tobramycin, Respiratory Tract Infections; Cystic Fibrosis
Date of authorisation: 18/02/2019, Revision: 5, Authorised, Last updated: 22/09/2023following intravenous and aerosolised administration, concurrent … -
List item
National expert: Wim Van Paesschen, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 45.95 KB | PDF
- Curriculum Vitae - 37.79 KB | PDF
activity Current 01-06- 2022 22-03- 2023 Angelini Pharma Individual product … -
List item
Human medicine European public assessment report (EPAR): Arikayce liposomal
Amikacin sulfate, Respiratory Tract Infections
Date of authorisation: 27/10/2020,
, Revision: 2, Authorised, Last updated: 04/08/2023
System (nebuliser handset, aerosol head and controller). For … diameter (MMAD) of the nebulised aerosol droplets is about 4.7 µm … -
List item
Human medicine European public assessment report (EPAR): Myozyme
alglucosidase alfa, Glycogen Storage Disease Type II
Date of authorisation: 28/03/2006, Revision: 25, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Regkirona
Regdanvimab, COVID-19 virus infection
Date of authorisation: 12/11/2021,
, Revision: 8, Authorised, Last updated: 25/08/2023
-
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta (updated)
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 25, Authorised, Last updated: 04/09/2023 -
List item
Human medicine European public assessment report (EPAR): Fortacin (updated)
lidocaine, prilocaine, Sexual Dysfunction, Physiological
Date of authorisation: 15/11/2013, Revision: 12, Authorised, Last updated: 22/09/2023 -
List item
Human medicine European public assessment report (EPAR): Abrysvo (updated)
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein / Respiratory syncytial virus, subgroup B, stabilized prefusion F protein, Respiratory Syncytial Virus Infections
Date of authorisation: 23/08/2023,, 
, Authorised, Last updated: 26/09/2023
-
List item
Human medicine European public assessment report (EPAR): Trydonis
Beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 26/04/2018, Revision: 5, Authorised, Last updated: 04/07/2023